First Header Logo Second Header Logo

Connection

Steven Feldman to Keratolytic Agents

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Keratolytic Agents.
Steven Feldman
Connection Strength
4.419
Keratolytic Agents
  1. Davis SA, Yentzer BA, Feldman SR. Acitretin prescribing patterns in women of childbearing potential. J Drugs Dermatol. 2013 Jul 01; 12(7):799-802.
    View in: PubMed
    Score: 0.442
  2. Ghasri P, Yentzer BA, Dabade TS, Feldman SR. Acitretin for the treatment of psoriasis: an assessment of national trends. J Drugs Dermatol. 2011 Aug; 10(8):873-7.
    View in: PubMed
    Score: 0.387
  3. Haushalter K, Murad EJ, Dabade TS, Rowell R, Pearce DJ, Feldman SR. Efficacy of low-dose acitretin in the treatment of psoriasis. J Dermatolog Treat. 2012 Dec; 23(6):400-3.
    View in: PubMed
    Score: 0.387
  4. Dunn LK, Gaar LR, Yentzer BA, O'Neill JL, Feldman SR. Acitretin in dermatology: a review. J Drugs Dermatol. 2011 Jul; 10(7):772-82.
    View in: PubMed
    Score: 0.385
  5. McClain R, Yentzer BA, Feldman SR. Keratolytics for psoriasis: are they necessary? Dermatol Online J. 2009 Jan 15; 15(1):11.
    View in: PubMed
    Score: 0.325
  6. Yelverton CB, Yentzer BA, Clark A, Pearce DJ, Balkrishnan R, Camacho FT, Boles A, Fleischer AB, Feldman SR. Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis. Arch Dermatol. 2008 Sep; 144(9):1224-5.
    View in: PubMed
    Score: 0.317
  7. Feldman S, Nighland M. Photographic assessment of tretinoin microsphere gel in moderate acne. J Drugs Dermatol. 2008 Aug; 7(8 Suppl):s19-24.
    View in: PubMed
    Score: 0.315
  8. Pearce DJ, Klinger S, Ziel KK, Murad EJ, Rowell R, Feldman SR. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis. Arch Dermatol. 2006 Aug; 142(8):1000-4.
    View in: PubMed
    Score: 0.274
  9. Conley J, Nanton J, Dhawan S, Pearce DJ, Feldman SR. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series. J Dermatolog Treat. 2006; 17(2):86-9.
    View in: PubMed
    Score: 0.263
  10. Feldman S. Efficacy is more easily assessed than safety. J Dermatolog Treat. 2004 Apr; 15(2):71.
    View in: PubMed
    Score: 0.233
  11. Balkrishnan R, Carroll CL, Camacho FT, Feldman SR. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol. 2003 Oct; 49(4):651-4.
    View in: PubMed
    Score: 0.225
  12. Heath MS, Sahni DR, Curry ZA, Feldman SR. Pharmacokinetics of tazarotene and acitretin in psoriasis. Expert Opin Drug Metab Toxicol. 2018 Sep; 14(9):919-927.
    View in: PubMed
    Score: 0.158
  13. Patel P, Lin HC, Feldman SR, Fleischer AB, Nahata MC, Balkrishnan R. Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States. J Drugs Dermatol. 2011 Jul; 10(7):766-71.
    View in: PubMed
    Score: 0.096
  14. Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011 May; 64(5):936-49.
    View in: PubMed
    Score: 0.094
  15. Yentzer BA, Irby CE, Fleischer AB, Feldman SR. Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data. Pediatr Dermatol. 2008 Nov-Dec; 25(6):635-9.
    View in: PubMed
    Score: 0.080
  16. Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R. Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat. 2006; 17(3):136-42.
    View in: PubMed
    Score: 0.066
  17. Balkrishnan R, Cayce KA, Kulkarni AS, Orsagh T, Gallagher JR, Richmond D, Feldman SR. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatolog Treat. 2006; 17(3):162-6.
    View in: PubMed
    Score: 0.066
  18. Feldman SR, Nijsten T, Margolis DJ, Rolstad T. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing. J Am Acad Dermatol. 2005 Jan; 52(1):140-1.
    View in: PubMed
    Score: 0.061
  19. Kulkarni AS, Balkrishnan R, Camacho FT, Anderson RT, Feldman SR. Medication and health care service utilization related to depressive symptoms in older adults with psoriasis. J Drugs Dermatol. 2004 Nov-Dec; 3(6):661-6.
    View in: PubMed
    Score: 0.061
  20. Cayce KA, McMichael AJ, Feldman SR. Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs. 2004 Oct; 16(5):401-6, 413-6; quiz 417.
    View in: PubMed
    Score: 0.060
  21. Lebwohl M, Menter A, Koo J, Feldman S. Case studies in severe psoriasis: A clinical strategy. J Dermatolog Treat. 2003; 14 Suppl 2:26-46.
    View in: PubMed
    Score: 0.053
  22. Davis SA, Sandoval LF, Gustafson CJ, Feldman SR, Cordoro KM. Treatment of preadolescent acne in the United States: an analysis of nationally representative data. Pediatr Dermatol. 2013 Nov-Dec; 30(6):689-94.
    View in: PubMed
    Score: 0.028
  23. Wong JW, Davis SA, Feldman SR, Koo JY. Trends in older adult psoriasis outpatient health care practices in the United States. J Drugs Dermatol. 2012 Aug; 11(8):957-62.
    View in: PubMed
    Score: 0.026
  24. Cayce KA, Feldman SR, McMichael AJ. Hyperpigmentation: a review of common treatment options. J Drugs Dermatol. 2004 Nov-Dec; 3(6):668-73.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.